CUBIST PHARMACEUTICALS INC 4

Accession 0001127602-14-010495

CIK 0000912183operating

View on SEC.gov Company Profile

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 4:38 PM ET

Size

33.4 KB

Accession

0001127602-14-010495

Insider Transaction Report

Form 4

Period: 2014-03-05

CUBIST PHARMACEUTICALS INCCBST

STEA GREGORY

SVP, Commercial Operations

Transactions

Exercise/Conversion
Common Stock
2014-03-05$21.56/sh+2,813$60,648→ 19,089 total
Exercise/Conversion
Common Stock
2014-03-05$34.80/sh+2,813$97,878→ 21,902 total
Exercise/Conversion
Common Stock
2014-03-05$41.60/sh+6,763$281,341→ 28,665 total
Sale
Common Stock
2014-03-05$79.57/sh−11,689$930,115→ 16,976 total
Sale
Common Stock
2014-03-05$80.07/sh−700$56,049→ 16,276 total
Exercise/Conversion
Common Stock
2014-03-05$42.09/sh+2,900$122,061→ 19,176 total
Sale
Common Stock
2014-03-05$79.96/sh−2,900$231,876→ 16,276 total
Exercise/Conversion
Common Stock
2014-03-06$42.09/sh+4,600$193,614→ 20,876 total
Sale
Common Stock
2014-03-06$79.99/sh−4,600$367,954→ 16,276 total
Exercise/Conversion
Stock Options (Right to Buy)
2014-03-05−2,813→ 5,625 total
Exercise: $21.56From: 2010-08-14Exp: 2020-05-14→ Common Stock (2,813 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2014-03-05−2,813→ 16,875 total
Exercise: $34.80From: 2011-08-13Exp: 2021-05-13→ Common Stock (2,813 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2014-03-05−6,763→ 29,309 total
Exercise: $41.60From: 2013-05-15Exp: 2023-02-15→ Common Stock (6,763 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2014-03-06−4,600→ 32,500 total
Exercise: $42.09From: 2012-05-16Exp: 2022-02-16→ Common Stock (4,600 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2014-03-05−2,900→ 37,100 total
Exercise: $42.09From: 2012-05-16Exp: 2022-02-16→ Common Stock (2,900 underlying)

Holdings

Common Stock
(indirect: By 401(k))
334

Footnotes (6)

[F1]Sold pursuant to a Rule 10(b)5-1 Plan.
[F2]This transaction was executed in multiple trades at prices ranging from $79.0000 to $79.9600. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
[F3]This transaction was executed in multiple trades at prices ranging from $80.0500 to $80.1200. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
[F4]This transaction was executed in multiple trades at prices ranging from $79.9000 to $80.1200. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
[F5]Option vests 6.25% quarterly over a four-year period.
[F6]Options vest 6.25% quarterly over a four-year period.

Documents

2 files

Issuer

CUBIST PHARMACEUTICALS INC

CIK 0000912183

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0000912183

Filing Metadata

Form type: 4
Filed: Mar 5, 7:00 PM ET
Accepted: Mar 6, 4:38 PM ET
Size: 33.4 KB

View on SEC.gov